Latest share price

Current

540.00p

Average

+26.00p LSE

+5.06% 15 min delay

View chart

Results, reports & presentations

Our financial reports, corporate presentations, webcasts and audio can be found in this section.

Go

Latest press releases

04/09/2019

Interim results for the six months ended 30 June 2019

Read more

26/06/2019

Oxford Biomedica and Santen enter R&D collaboration and Option &...

Read more

06/06/2019

Oxford Biomedica notes Axovant's six-month update from first cohort of...

Read more

See all

Regulatory news

Message from the CEO
John Dawson

 

Message from the CEO 
John Dawson

Management and DirectorsGo

Shareholder meetings, circulars, and prospectusesGo

Analyst coverageGo

Corporate governanceGo

Financial calendarGo

Investor contactsGo

Email alertsGo